Trial intelligence / Profile preview

Incidence of Intravascular Injection in S1 TFESI: Medial vs Lateral Approach

NCT02867046Completed

Sponsor
Yonsei University
Start
Jul 2016
Primary completion
Nov 2016
Modality
Orthosteric Ligands
Countries
1
01

Overview

Randomised, open-label trial of dexamethasone in lumbosacral radiculopathy (2 arms), sponsored by Yonsei University. Primary endpoint: The incidence of intravascular injection in S1 foramen. Started Jul 2016; status: completed.

02

Drugs

dexamethasone
03

Conditions

lumbosacral radiculopathy

Beyond the preview

Go deeper on NCT02867046.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02867046.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call